These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 10028078

  • 1. Assessment of complement deficiency in patients with meningococcal disease in The Netherlands.
    Fijen CA, Kuijper EJ, te Bulte MT, Daha MR, Dankert J.
    Clin Infect Dis; 1999 Jan; 28(1):98-105. PubMed ID: 10028078
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency.
    Ross SC, Densen P.
    Medicine (Baltimore); 1984 Sep; 63(5):243-73. PubMed ID: 6433145
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Properdin deficiency in a family with fulminant meningococcal infections.
    Sjöholm AG, Braconier JH, Söderström C.
    Clin Exp Immunol; 1982 Nov; 50(2):291-7. PubMed ID: 7151327
    [Abstract] [Full Text] [Related]

  • 6. [Occurrence of complement defects in meningococcal disease: who should be examined?].
    Nielsen HE, Magnussen P, Lind I.
    Ugeskr Laeger; 1991 Apr 15; 153(16):1113-6. PubMed ID: 1902602
    [Abstract] [Full Text] [Related]

  • 7. Complement factor 7 gene mutations in relation to meningococcal infection and clinical recurrence of meningococcal disease.
    Kuijpers TW, Nguyen M, Hopman CT, Nieuwenhuys E, Dewald G, Lankester AC, Roos A, van der Ende A, Fijen C, de Boer M.
    Mol Immunol; 2010 Jan 15; 47(4):671-7. PubMed ID: 19931914
    [Abstract] [Full Text] [Related]

  • 8. Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine.
    Fijen CA, Kuijper EJ, Drogari-Apiranthitou M, Van Leeuwen Y, Daha MR, Dankert J.
    Clin Exp Immunol; 1998 Dec 15; 114(3):362-9. PubMed ID: 9844044
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.
    Ceyhan M, Yildirim I, Balmer P, Riley C, Laher G, Andrews N, Borrow R, Kurt N, Turgut M, Aydogan A, Ecevit C, Uysal G, Schultze V.
    Vaccine; 2007 Oct 10; 25(41):7233-7. PubMed ID: 17707957
    [Abstract] [Full Text] [Related]

  • 11. Complement and properidin deficiencies in meningococcal disease.
    Mathew S, Overturf GD.
    Pediatr Infect Dis J; 2006 Mar 10; 25(3):255-6. PubMed ID: 16511390
    [No Abstract] [Full Text] [Related]

  • 12. Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups.
    Fijen CA, Kuijper EJ, Hannema AJ, Sjöholm AG, van Putten JP.
    Lancet; 1989 Sep 09; 2(8663):585-8. PubMed ID: 2570284
    [Abstract] [Full Text] [Related]

  • 13. The role of Fcgamma receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals.
    Fijen CA, Bredius RG, Kuijper EJ, Out TA, De Haas M, De Wit AP, Daha MR, De Winkel JG.
    Clin Exp Immunol; 2000 May 09; 120(2):338-45. PubMed ID: 10792385
    [Abstract] [Full Text] [Related]

  • 14. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002.
    Brooks R, Woods CW, Benjamin DK, Rosenstein NE.
    Clin Infect Dis; 2006 Jul 01; 43(1):49-54. PubMed ID: 16758417
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Association between combined properdin and mannose-binding lectin deficiency and infection with Neisseria meningitidis.
    Bathum L, Hansen H, Teisner B, Koch C, Garred P, Rasmussen K, Wang P.
    Mol Immunol; 2006 Feb 01; 43(5):473-9. PubMed ID: 16337490
    [Abstract] [Full Text] [Related]

  • 17. Serum factors and polymorphonuclear leukocytes in human host defence against Neisseria meningitidis. Studies of interactions with special reference to a chemiluminometric technique.
    Fredlund H.
    Scand J Infect Dis Suppl; 1993 Feb 01; 87():1-72. PubMed ID: 8511525
    [Abstract] [Full Text] [Related]

  • 18. Multicenter surveillance of invasive meningococcal infections in children.
    Kaplan SL, Schutze GE, Leake JA, Barson WJ, Halasa NB, Byington CL, Woods CR, Tan TQ, Hoffman JA, Wald ER, Edwards KM, Mason EO.
    Pediatrics; 2006 Oct 01; 118(4):e979-84. PubMed ID: 17015517
    [Abstract] [Full Text] [Related]

  • 19. Recent epidemiological changes in meningococcal disease may be due to the displacement of serogroup A by serogroup C in Hefei City, China.
    Ni JD, Jin YH, Dai B, Wang XP, Liu DQ, Chen X, Zheng Y, Ye DQ.
    Postgrad Med J; 2008 Feb 01; 84(988):87-92. PubMed ID: 18322129
    [Abstract] [Full Text] [Related]

  • 20. Complement deficiencies in selected groups of patients with meningococcal disease.
    Nielsen HE, Koch C, Magnussen P, Lind I.
    Scand J Infect Dis; 1989 Feb 01; 21(4):389-96. PubMed ID: 2511621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.